The Board denied service connection for MGUS as the evidence did not support a relationship between the Veteran's current diagnosis and his active service, including exposure to contaminated water at Camp LeJeune.
The deciding factor: The preponderance of the evidence does not support a link between the Veteran’s MGUS and his active service or exposure to contaminated water at Camp LeJeune.
- Claimed conditions
- Monoclonal gammopathy of undetermined significance (MGUS)
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- Camp Lejeune water
- Rating
- Not verified here — check the original decision
- Decision date
- February 5, 2019
- Citation
- 19108531
Veterans Law Judge
Decisions by this judge: 1,104 · Granted: 28% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 19108531.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Veteran's claim for a compensable rating for monoclonal gammopathy of undetermined significance (MGUS) is denied. The claim for service connection for bone cancer is also denied.
- Whole decision: Remanded (sent back)
The Board has decided to remand the claims for MGUS and right knee disability due to a lack of examinations, which may provide additional evidence on the etiology of these conditions.
- Whole decision: Denied
The Veteran's service-connected monoclonal gammopathy of undetermined significance (MGUS) has not manifested to symptomatic multiple myeloma, and thus does not warrant a compensable rating.
- Whole decision: Remanded (sent back)
The Board has remanded the case for a medical opinion regarding whether the Veteran's MGUS is related to herbicide agent exposure, and also for a determination on an initial compensable rating for MGUS.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.